Will healthcare mergers lead to debt concerns?

Cara Livernois | June 17, 2016 | Health Exec | Economics

With the announcement of a possible merger between AmSurg and Envison Healthcare Holdings the promise of “lower rates” was once again stated, but will rates actually drop? And if so how long will they stay down?

“The reality is leverage today is not a great thing,” said Envision CEO William Sanger. “I think there’s a fair amount of uncertainty in terms of how long these rates stay in place.”

Around the web

Cardiovascular Business

Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business

FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country.

Cardiovascular Business

Cardiology groups cheer new bill that would improve access to Medicare claims data

If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation.

Will healthcare mergers lead to debt concerns?

Related Content

Around the web